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Immunodominant Epitope of MBP Complexed with I-Au
not been demonstrated (Corper et al., 2000; Latek et al.,
2000; Lee et al., 2001; Smith et al., 1998). In the case
of I-Ag7 from the nonobese diabetic mouse (NOD), a
widening of the p9 MHC pocket was observed, but the
link to disease is not obvious (Corper et al., 2000; Latek
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The immunodominant encephalitogenic T cell epitope2 Center for Immunology and
of MBP, in mice of the H-2u haplotype (PL/J or B10.PL),Cancer Immunobiology Center
is the acetylated N-terminal 9- or 11-mer (Ac1-11,University of Texas-Southwestern Medical Center
AcASQYRPSQRHG). The Ac1-11 epitope in the contextDallas, Texas 75390
of I-Au has been extensively characterized in functional3 Epimmune Inc.
studies, which have revealed a number of unusual fea-San Diego, California 92121
tures in this system (Acha-Orbea et al., 1988; Urban et
al., 1988; Fairchild et al., 1993; Fugger et al., 1996; Gau-
tam et al., 1992a, 1992b; Mason et al., 1995; Wraith etSummary
al., 1989, 1992; Pearson et al., 1999). First, a posttransla-
tional modification to the MBP peptide, N-terminal acet-Murine experimental allergic encephalomyelitis (EAE)
ylation, is required for induction of EAE (Zamvil et al.,is a useful model for the demyelinating, autoimmune
1986). Second, despite being the immunodominant epi-disease multiple sclerosis. In the EAE system, the im-
tope in vivo, Ac1-11 binds to I-Au very weakly (t1/2  15munodominant N-terminal epitope of myelin basic
min) (Fairchild et al., 1993; Fugger et al., 1996; Masonprotein (MBP) is an unusually short, weakly binding
et al., 1995). This low affinity results in escape of I-Au/peptide antigen which elicits highly biased TCR chain
Ac1-11-specific T cells from central tolerance induction,usage. In the 2.2 A˚ crystal structure of I-Au/MBP1-11
resulting in immunodominance of this epitope followingcomplex, only MBP residues 1–7 are bound toward
immunization of mice with MBP. Consistent with this,one end of the peptide binding cleft. The fourth residue
in MBP-deficient mice other epitopes of MBP becomeof MBP1-11 is located in an incompatible p6 pocket
immunodominant (Harrington et al., 1998). Substitutionof I-Au, thus explaining the short half-life of I-Au com-
of position four lysine (MBP4-Lys) of MBP with severalplexed with Ac1-11. MBP peptides extended at the C
other residues (e.g., Ala, Tyr) greatly increases the stabil-terminus of Ac1-11 result in dramatic affinity in-
ity of the I-Au-peptide complexes. Surprisingly, an in-creases, likely attributed to register shifting to a higher
verse correlation has been observed between the affinityaffinity cryptic epitope, which could potentially mask
of P4 variants of Ac1-9 for I-Au and the ability of thethe presentation of the immunodominant MBP1-11
peptide to induce EAE (Anderton et al., 2001; Fairchildpeptide during thymic education.
et al., 1993; Mason et al., 1995; Wraith et al., 1989).
A still further unusual feature is that I-Au/Ac1-11-spe-Introduction
cific T cells, the vast majority of which exhibit a highly
biased TCR chain usage for V8.2, can respond to trun-The activation of CD4 T cells by peptide-MHC com-
cated MBP peptides as short as Ac1-6 (Gautam et al.,plexes is a key event in the induction of autoimmune
1994). Most peptide antigens restricted to class II MHCdiseases such as multiple sclerosis (MS) and rheumatoid
are between 12–15 amino acids in length and traverse
arthritis (RA). For MS, murine experimental allergic en-
the length of the MHC groove. Hence, it has been specu-
cephalomyelitis (EAE) represents an intensively studied
lated from modeling studies that only the N-terminal six
model system for understanding autoimmunity to neural amino acids of Ac1-11 lie in the MHC binding groove
self-antigens such as myelin basic protein (MBP), myelin (Gautam et al., 1994; Lee et al., 1998). This would result
oligodendrocyte protein (MOG), and proteolipid protein in a partially empty MHC groove, presenting a truncated
(PLP) (Goverman, 1999; Steinman, 1996; Zamvil and peptide to a TCR, which would be unprecedented.
Steinman, 1990). Finally, it has been shown that cryptic epitopes (Ser-
Class II MHC I-A molecules are usually the restriction carz et al., 1993) within the MBP sequence could, in
elements for murine autoimmune models (Tisch and principle, compete with the immunodominant Ac-11 epi-
McDevitt, 1996). Structural features of I-Ad, I-Ak, and I-Ag7 tope for binding to I-Au (Fairchild et al., 1996). Whether
are consistent with promiscuous peptide binding motifs such cryptic epitopes are generated during natural pep-
in I-A epitopes (Corper et al., 2000; Fremont et al., 1998; tide processing in the class II MHC peptide loading path-
Latek et al., 2000; Scott et al., 1998), in contrast to the way is still uncertain. However, such epitopes, if gener-
more restricted motifs found in I-E (Rammensee et al., ated from naturally processed MBP, would be expected
1995). The somewhat promiscuous nature of I-A may to effect the development of the T cell repertoire in H-2u
give rise to inefficient negative selection of autoreactive mice.
T cells. Currently, a clear structural relationship between Here we present a structural analysis of a recombinant
an autoimmune MHC-peptide complex and disease has I-Au/MBP1-11 complex in tandem with MBP peptide
substitution studies. Strikingly, we find that the I-Au pep-
tide binding groove contains only the first seven resi-4 Correspondence: kcgarcia@stanford.edu
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Figure 1. Bioactivity and Three-Dimensional Structure of I-Au/MBP1-11
(A) Engineered, recombinant I-Au/MBP1-11(P4-Tyr), expressed from Drosophila melanogaster (crystallized for this study) and baculovirus
(Radu et al., 1998), effectively stimulate the Ac1-11-specific T cell hybridoma 172.10 (Urban et al., 1988) (see Experimental Procedures for
details).
(B) Side view of the electron density of the MBP peptide, including the residual leader peptide after processing. The electron density is a
2.2 A˚ SIGMAA omit map of the peptide (Read, 1986). In front of the electron density is a tube representation of the  chain helix, and in back
of the peptide is the  chain helix.
(C and D) Side view (C) and top view (D) (into the peptide binding groove) of ribbons representation of the I-Au/MBP1-11 structure.  chain
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dues of the MBP1-11 peptide. With the exception of the Table 1. Crystallographic Statistics
hydrophobic p6 pocket, the molecular nature of the I-Au
Data Collectionpeptide binding groove is largely devoid of highly spe-
Space group C2221cific peptide recognition features. Extensions to the
Unit cell (A˚) (a, b, c) 99.15, 110.59, 94.84Ac1-11 C terminus dramatically enhance the affinity for
Source SSRL, BL7-1I-Au, a phenomenon which appears to be due to register
Resolution (A˚) (highest resolution shell) 50.0–2.2 (2.3–2.2)shifting to a cryptic epitope proximal to the immuno-
Measured reflections 144,694
dominant sequence. Unique reflections 26,280
Completeness (%) 98.3 (98.5)
I/ (I) 6.7 (1.6)
Results Rmerge (%)a 8.0 (45.0)
Refinement Statistics
Expression of I-Au/MBP1-11
Resolution range (A˚) 50.0–2.3 (2.3–2.2)Due to the short half-life of I-Au complexed with native
Rcrystb 0.248 (0.323)MBP Ac1-11 (Fairchild et al., 1993; Mason et al., 1995;
Rfreec 0.276 (0.354)Fugger et al., 1996) and the necessity of a posttransla- No. of atoms (protein solvent) 3157, 450
tional acetylation of the peptide N terminus, expression Average B factors (A˚2) (I-Au, MBP1-11, 49.5, 57.4, 86.3, 56.8
of recombinant complexes required the design of bio- oligosaccharides, solvents)
Rms deviation from idealitychemically stable protein, which behaved in all ways
Bond lengths (A˚) 0.008like the native molecule (Figure 1A). I-Au was expressed
Bond angles () 1.4from Drosophila melanogaster with the MBP1-11 pep-
Dihedrals (), impropers () 25.5, 0.8
tide covalently linked to the N terminus of the I-Au  Bonded B factors (A˚2) main chain, 2.2, 2.9
chain through an eight-residue linker. Earlier studies side chain
indicated that empty I-Au or I-Au complexed with the Ramachandran plot (%) (favored, 87.3, 12.4, 0.3, 0
allowed, generous, disallowed)wild-type MBP1-11 is unstable (Radu et al., 2000), most
likely because of the low affinity of this epitope for I-Au. a Rmergehkl|I	I
|/hklI, where I is the intensity of unique reflection
We therefore used the higher affinity MBP4-Tyr mutant, hkl, and I
 is the average over symmetry-related observation of
unique reflection hkl.which allowed secretion of the stable complex. This
b Rcryst  |Fbobs 	 Fcalc/Fobs, where Fobs and Fcalc are the observedsubstitution enhances binding of the peptide to I-Au by
and the calculated structure factors, respectively.1500-fold (Fugger et al., 1996), without affecting T cell
c Rfree is R using 5% of reflections sequestered before refinement.recognition (Figure 1A) (Anderton et al., 2001; Wraith et
al., 1992).
acting with recombinant Ac1-11-specific TCRs. The
N-Terminal Residues of Peptide in the Groove structure was determined to 2.2 A˚ (Table 1).
To recapitulate the posttranslational acetylation of the
MBP N terminus, we engineered a glycine residue at
Overview of the StructureMBP-0, whose carbonyl group and -carbon atom faith-
The polypeptide main chain of the I-Au  heterodimerfully mimic the acetyl group found in MBP. N-terminal
is representative of the overall fold of other MHC II andsequencing of the secreted proteins revealed that three
I-A molecules previously reported (Figure 1C) (Corperadditional residues from the leader sequence (Ser-Arg-
et al., 2000; Fremont et al., 1998; Latek et al., 2000; ScottGly at P-3, P-2, and P-1, respectively) remain at the
et al., 1998; Stern and Wiley, 1994). The amino-terminalamino-terminus after processing (Figure 1B). The leader
domains of the heterodimer together form a characteris-sequence-derived P0-Gly and P-1-Gly main chain N
tic peptide binding groove like other class II moleculesatoms form H bonds to I-Au groove residues in a fashion
(Figure 1D). The I-Au backbone residues superimposesimilar to that seen in longer class II binding peptides,
closely with I-Ak, I-Ad, and I-Ag7 giving low root meanhaving the resultant effect of ordering the artificial leader
square deviations of 0.57, 0.59, and 0.60 A˚ for all com-extension as it extends out of the groove (Figures 1B
mon C positions, respectively (Figure 1E). One notice-and 1D). The additional leader peptide residues do not
able exception involves a displacement of one turn ofinfluence the functional properties of the I-Au/MBP com-
the I-Au  helix, in the 60-71 region toward the peptide,plex relative to the natural I-Au complexed with free pep-
which results in a narrowing at the end of the peptidetide (Figure 1A). Recombinant I-Au/MBP1-11 complexes
binding groove (Figure 1E) (discussed below).were secreted from both Drosophila melanogaster and
baculovirus using different signal sequences (with differ-
ent processing sites), and both complexes are effective The MBP1-11 Peptide Partially Occupies the Groove
The most striking feature of this structure is that the I-Auin stimulating IL-2 secretion by I-Au-Ac1-11-specific T
cell hybridomas/transfectants (Figure 1A) and inter- peptide binding groove contains only the first seven
is green,  chain is light blue, the peptide is colored purple, and the residual leader peptide remaining from the expression vector is in gray.
(E) The backbones of I-Au and I-Ak (Fremont et al., 1998) were superimposed in this view into the peptide binding groove. I-Au is colored cyan,
with the MBP peptide purple and leader peptide gray, and I-Ak is colored green, with the HEL peptide yellow. The location of the  chain
helix displacement toward the MBP peptide is circled.
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and eleven, plus the eight residue Gly-Ser linker con-
nected to the  chain N terminus, lie outside of the
groove and have disordered electron density (Figure
1B). The recombinant, covalent peptide complexes po-
tently activate Ac1-11-specific T cells (Figure 1B). There-
fore, the register of the natural Ac1-11 peptide is the
same as the covalently bound peptide in this structure,
which is also consistent with functional and modeling
studies of Ac1-11 bound to I-Au (Lee et al., 1998).
The unique binding mode of the MBP1-11 peptide to
I-Au is determined by the occupied MHC anchor posi-
tions at p4, p6, and p9 (Table 2); these residues would
normally comprise TCR-contact residues. As a result,
the exposed regions (MBP3-Gln, MBP6-Pro) of the pep-
tide, which would point downward and fill MHC pockets
in a canonical register, now point outward and comprise
the TCR-contact residues (Figure 3).
Implications for Empty MHC
The p1 pocket of I-Au is occupied by several ordered
water molecules, which probably contribute to the struc-
tural integrity of the pocket (Figure 2). The structure of
Figure 2. Molecular Surface Complementarity between the I-Au this pocket in I-Au is not perturbed in comparison with
Groove and the MBP Peptide
MHC structures whose p1 pocket is filled with an amino
To depict the natural Ac-11 peptide, the residual leader peptide acid side chain, suggesting that incomplete occupancy
residues have been removed from the structure. Molecular surfaces
is sufficient to stabilize the MHC groove, which has beenof I-Au (blue) with bound MBP peptide (purple) were produced, and
shown to exist as a molten globule, or partially foldedthe figures show planar cross sections through these surfaces to
illustrate the shape and complementarity between peptide and protein, in a completely empty state (Bouvier and Wiley,
MHC, as well as unfilled pockets and ordered water molecules (red 1998; Zarutskie et al., 1999). The I-Ad/OVA and HA struc-
spheres). The MBP peptide is shown within the surface as silver tures show a poor peptide fit in the p1 pocket due to
sticks. (A) is a side view, as in Figure 1C, and (B) is the groove the use of undersized side chains at the P1 peptide
viewed from the top, as in Figure 1D. Due to the planar cross section
residue (Scott et al., 1998). This common theme in I-Aof the convoluted surfaces, some residues of the peptide are sliced
structures implies that p1 pocket usage is not crucialout of view, such as P5-Arg, which extends toward the reader in (A)
and (B). In (A), the large and spacious p6 pocket is apparent, as are for peptide binding to I-A molecules, which may contrib-
the ordered water molecules in the p1 and p6 pockets. In (B), the ute to their promiscuity (Scott et al., 1998).
empty p1 pocket is in the far left of the blue I-Au molecular surface,
and the p7 pocket, where the P5-Arg resides, extends sideways but
does not appear occupied by P5-Arg due to the cross section. The N-Terminal Acetylation of the MBP Peptide
molecular surfaces were produced using a 1.4 A˚ probe radius. Is Required for MHC Binding
As MBP is naturally acetylated at its N terminus, Ac1-
11 is a rare case of a peptide antigen which requires a
posttranslational modification for MHC presentation (theresidues of the MBP1-11 peptide (Figures 1 and 2), indi-
cating that the natural Ac1-11 complex leaves the p1 other example being the formylated peptide bound to
H2M3 [Wang et al., 1995]). The nonacetylated MBP1-11and p2 pockets empty, as depicted in Figure 2. Previous
crystal structures of class II MHC-peptide complexes peptide is incapable of inducing EAE (Zamvil et al.,
1986). In the recombinant protein, the peptide bond ofcontain grooves completely filled with 12–17 amino acid
peptides that freely protrude from the ends of the open the artificially engineered P0-Gly mimics the acetyl
group (Figures 1C and 3A). Structurally, the carbonyl ofgroove (e.g., I-Ak in Figure 1E). The MBP1-11 peptide is
bound to I-Au in an extended type II poly-proline confor- the P0-Gly is hydrogen bonded to the N2 of Asn82 in
an H-bonding interaction similar to that seen in a normalmation, as previously observed in other class II struc-
tures, except that the register of peptide is shifted by length peptide main chain carbonyl (Figure 3A and Table
2). The hydrogen-bonded acetyl group not only en-two residues such that the MBP1-Ala resides where the
P3 peptide residue is normally located in canonically hances the peptide binding affinity but also neutralizes
the N terminus, which would otherwise be charged andregistered class II peptide-MHC complexes (Figure 1E).
As discussed, three additional N-terminal residues from energetically unfavorable for burial within the groove.
As opposed to the buried terminal peptide charges inthe linker sequence remain connected to the amino ter-
minus of the peptide (Figure 1), but the p1 pocket is not class I MHC (Madden, 1995), no other MHC II/peptide
complexes have their charged N or C termini within theoccupied by a peptide side chain since P-1 is a glycine.
The absence of side chains in the p1 and p2 pockets groove (Stern and Wiley, 1994); rather, they extend out
of the open ends of the groove (e.g., I-Ak in Figurespresumably resembles the empty pockets which would
be found in vitro and in vivo for I-Au complexed to natu- 1E and 4). In MBP1-11, the neutralized P1 N-terminal
nitrogen atom resides within a solvent exposed, hy-rally processed Ac1-11 (Figure 2). At the C-terminal end
of the covalent peptide, MBP residues eight, nine, ten, drophobic patch composed of Phe54, Phe24, and
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Table 2. Intermolecular Contacts between I-Au and MBP1-11 Peptide
Hydrogen Bonds between MBP1-11 Peptide and I-Au
MBP 1-11 I-Au Distance (A˚)
(leader) Gly-1 N S53 O 2.8
Gly0 N N82 O1 3.0
Gly0 O N82 N2 3.1
Ser2 N Y9 O 3.0
Ser2 O Y26 OH 3.2
Gln3 N E74 O2 3.2
Tyr4 N N62 O1 2.7
Arg5 N Y30 OH 3.0
Arg5 N2 E74 O1 2.7
Arg5 O Y61 OH 2.5
Pro6 O Y66 OH 2.5
Ser7 N N69 O1 3.2
Ser7 O N69 O1 3.2
Van der Waals Contacts (4.5 A˚ cutoff)
MBP 1-11 Neighboring I-Au Residues
(leader) Ser-3 R52, S53, Y81, E85
(leader) Arg-2 S53, Y81
(leader) Gly-1 S53, N82, T86
Gly0 Y9, F24, V78, T86
Ala1 Y9, Y22, F24, F54, V78
Ser2 Y9, Y26, P13, F11, E74, V78
Gln3 F11, E74
Tyr4 V11, N62, T65, G66, N69, V9, Q10, F11, Y30
Arg5 T65, N69, Y30, Y61, Y67, R70, E74
Pro6 T65, H68, N69, Y60, Y61, Y67
Ser7 H68, N69, V72, D57, Y60, Y61
Gln8 P56, Y60
Val28, which is a region of TCR contact in class II MHC/ tion of a large, bulky residue in the bound peptide. There
is a Gly66 in I-Au where most other class II MHC haveTCR complexes (Reinherz et al., 1999).
a large side chain that reduces the volume of the pocket.
The shaft of the pocket is lined by hydrophobic residuesA Narrow p4 Pocket
The I-Au p4 pocket is unique when compared with other Phe11 and Tyr30 and the aliphatic portions of Asn62
and Thr65 (Figure 3B). The base of the pocket is amphi-mouse MHC II alleles (Figures 2 and 3). In I-Au, the vol-
ume of the p4 pocket is substantially reduced by substi- pathic with the capacity for both polar and nonpolar
interactions.tution of a Tyr residue (Tyr26) for the more common,
and substantially smaller, Leu26 found on the side wall
of the pocket in other I-A alleles. The MBP2-Ser only A Key Interaction between MBP4
and the I-Au p6 Pocketpartially occupies the p4 pocket, hydrogen bonding to
Tyr26, with the remaining space in the pocket filled by In the structure, the p6 pocket is occupied by the MBP4
amino acid position (Figures 2 and 3B). Class II MHC-a well-ordered water molecule at the base of the cavity.
The primary stabilizing force in this pocket is likely hy- peptide complexes in normal registers occupy the p6
pocket with the P6 residue of the peptide. In the naturaldrophobic complementarity, as substitution of MBP2-
Ser with Ala does not result in weaker binding of MBP1- MBP sequence, residue number four is a lysine (Figure
4). In our structure, we have crystallized the MBP4-Lys
11 (Figure 4) (Gautam et al., 1994).
MBP4-Tyr mutant of the MBP1-11 peptide due to its
higher affinity for I-Au (Figure 4) (Fairchild et al., 1993;A Cavernous p6 Pocket
Biochemical and functional studies have converged on Mason et al., 1995; Fugger et al., 1996). In the complex,
the MBP4-Tyr side chain is deeply buried in the p6the I-Au p6 pocket and MBP4 residue as central to the
stability of the I-Au/MBP complex (Fairchild et al., 1993; pocket. The MBP4-Tyr aromatic ring is stacked between
Phe11 and Tyr30 in the pocket’s neck region, and theFugger et al., 1996; Mason et al., 1995, Pearson et al.,
1999), as well as key to its interesting autoimmune char- phenolic hydroxyl is H bonded to a water molecule linked
to the base of the pocket (Figure 3B).acteristics in vitro and in vivo (Anderton et al., 2001;
Pearson et al., 1997; Wraith et al., 1989). The p6 pocket Why does Lys at the P4 position of native MBP desta-
bilize the I-Au complex relative to the MBP4-Tyr andis exceptionally large (Figures 2 and 3B) in I-Au. This is
due to smaller side chains in the I-Au p6 pocket com- MBP4-Ala variants? There are no charged MHC residues
in this pocket to counterbalance the positive charge ofpared to the corresponding positions of other class II
MHC. The chemical environment of the p6 pocket is a the terminal N atom of a Lys, which likely accounts
for the low affinity of the corresponding peptide/MHCcombination of a hydrophobic neck and a moderately
hydrophilic base (Figure 3B), which favors accommoda- interaction. However, stabilization forces are likely de-
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Figure 3. MBP Peptide Interactions with I-Au
The orientation is as for the side view shown in Figure 1, with the peptide (purple) N terminus to the left and C terminus to the right. I-Au 
chain helix is in front (gray tube), and  chain helix is in back (gray) of the peptide. The residues of I-Au which interact with the peptide are
drawn as cyan. H bonds are indicated as green dots. Relevant residues are labeled for the (A) N-terminal, (B) central, and (C) more C-terminal
MBP peptide interactions with I-Au.
rived from: (1) the aliphatic portion of Lys making numer- (Figure 4). Further, the low affinity of the native (MBP4-
ous van der Waals’ interactions with the hydrophobic Lys) I-Au/MBP1-11 complex results in escape from nega-
walls of the pocket, (2) the polarity of the Lys amino tive selection of autoreactive T cells. The MBP4-Ala vari-
may coordinate water at the base of the pocket, as seen ant is more stable than MBP4-Lys but of lower stability
for P4-Tyr, and (3) flanking interactions between I-Au than the MBP4-Tyr (Figure 4). The MBP4-Ala substitu-
and the MBP acetyl group, MBP2-Ser, MBP5-Arg, and tion would result in a loss of favorable hydrophobic
MBP7-Ser. In total, the cumulative effect of these coun- interactions at the pocket neck, while removing the im-
terbalancing interactions appears sufficient to stabilize pact of an unfavorable positive charge. The progressive
even the suboptimal MBP4-Lys (t1/2 15 min) sufficiently affinity increases as the size and hydrophobicity of
with I-Au during T cell recognition for activation to occur MBP4 is increased (i.e., Ala, Val, Met, and Trp), and this
(Fugger et al., 1996). can now simply be interpreted as an enhancement of
the hydrophobic complementarity to the p6 pocket.
I-Au is unusual in that MBP peptides as short as theStructural Basis for the Functional Differences
N-terminal six residues of the Ac1-11 peptide bind tobetween Immunodominant MBP Peptide Variants
this MHC and can induce EAE (Gautam et al., 1992a,Substitution of MBP4-Lys with Ala, Val, or Tyr variants
1992b, 1994). Normal length peptides restricted by classresults in peptides that are ineffective, even antagonis-
tic, in inducing EAE and have higher affinity for I-Au II MHC molecules vary between 12–17 amino acids.
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Figure 4. MBP Variants and the Presence of a Pseudo-Register in the MBP Sequence
The natural Ac1-11 sequence is peptide number 1, and the MBP sequence in our structure is peptide number 21. The experimental results
shown in (A) are depicted in (B) as schematic models for the two possible registers of MBP1-7 (purple) and 8-18 (red) found, for example, in
peptide number 16 from (A). The left model is the register seen in our structure (left), and the right model is the likely register adopted when
MBP is extended at the C terminus, as shown for peptide numbers 8 through 18 in (A). The regions of the MBP peptide that are shown to
extend out of the groove are arbitrarily drawn main chain atoms for illustrative purposes only. MBP125-136 and 136-146 (bottom two rows
of [A]) have been predicted to bind in a canonical register (Loftus et al., 1999).
It is clear from this structure that MBP1-7 is located in Arg assumes integral structural roles in MHC stability
and also influences the topology of the T cell epitope,the middle and C-terminal part of the peptide binding
groove, with the MBP8-11 largely extended beyond the through both intermolecular interactions with I-Au and
intramolecular interactions within the peptide (Figuregroove and playing no role in the interaction with I-Au.
3C). The MBP5-Arg is located within a narrow and hy-
drophobic p7 pocket, in which the aliphatic portion ofInter- and Intramolecular Interactions by P5-Arg
the MBP5-Arg is packed against the hydrophobic wallSubstitution of the MBP5-Arg affects both MHC and T
of the groove, and its guanidinium group is involved in ancell recognition (Gautam et al., 1994; Wraith et al., 1992).
Consistent with this data, in the structure the MBP5- extensive hydrogen-bonding network (Figure 3C). The
Immunity
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MBP5-Arg guanidinium group is salt bridged to Glu74
of I-Au in an intermolecular contact. Additionally, the
MBP5-Arg N2 is H bonded to the MBP3-Gln O1 atom,
and the MBP5-Arg N atom is H bonded to the peptide
main chain (MBP3-Gln carbonyl oxygen) in intramolecu-
lar contacts (Figure 3C). These interactions effectively
prevent clear solvent exposure of MBP5-Arg. The com-
bination of both inter- and intramolecular contacts
would be manifested in the mutational effects of MBP5-
Arg (Gautam et al., 1994; Wraith et al., 1992) perturbing
the MBP3-Gln position (a TCR contact), as well as the
peptide-helix interaction that is constrained by the salt-
bridge with Glu74 (Figures 1E and 3C).
The p9 Pocket
The p9 pocket of I-Au is only partially filled by MBP7-
Ser (Figures 2 and 3). This loose fit is compensated for,
in part, by a hydrogen bond between MBP7-Ser O and
O1 of Asn69 (Figure 3C). This hydrogen bond is, in
fact, important to the overall I-Au/MBP stabilization since
deletion of MBP7-Ser severely reduces the I-Au affinity
for MBP1-6, but substitution to Thr maintains the inter-
action (Figure 4). The p9 pocket appears quite permis-
sive to a variety of small residues. Beyond the p9 pocket,
only the main chain of MBP8-Gln is visible in the electron
density, with the remaining four MBP residues and the
eight-residue linker to the  chain N terminus disor-
dered.
Figure 5. Schematic of Predicted TCR Footprints over the Compos-
ite Peptide-MHC Surfaces of I-Au/MBP (top) and I-Ak-HEL (bottom)
Peptide Binding Specificity and a Cryptic Epitope To depict the natural Ac1-11 peptide, we have removed the residual
In the light of this structure, we asked what effect on leader peptide residues seen in our engineered construct (i.e., Figure
binding is seen by extending the MBP peptide at the C 1B). An approximate diagonal orientation was achieved to represent
the TCR V and V chain overlying footprints on the MHC. The exactterminus stepwise with the natural MBP sequence (Fig-
footprints cannot be known in the absence of a TCR/pMHC complexure 4), as would be seen in vivo for naturally processed
structure, so the orientations are ambiguous to allow for the range12- to 18-mers presented by class II. We sequentially
of orientations so far seen in class I and class II TCR/pMHC complexadded one amino acid at a time to the C terminus of structures. In this representation, it is clear that the TCR V domain
Ac1-11 to a final peptide length of 22 amino acids and would be positioned largely over an empty region of the I-Au groove
expressed binding strength in terms of an inhibitory con- in the MBP complex, irrespective of whether the exact orientation
tends toward the perpendicular or diagonal.stant (IC50) relative to a known tight binding peptide. As
Figure 4 shows, these C-terminal additions resulted in
a sequential increase in affinity from unmeasurably weak
would better fit a canonical class II epitope than the(peptide numbers four though ten, including Ac1-7[P4-
MBP1-7, 1-9, or 1-11 peptides. Currently, there are noLys]) to 17 nM IC50 for peptide number 18 (Figure 4). We
experimental data which demonstrate that the longerexamined the sequences of the C-terminal additions
epitopes we produced synthetically can be generated inand found that the major I-Au contact positions MBP2,
vivo by MBP processing (Fairchild et al., 1996). However,MBP4, and MBP9 are repeated at residues MBP12-Ser,
MBP5-20 can be generated from MBP1-20. CertainlyMBP14-Tyr, and MBP17-Thr (instead of Ser) of MBP
a myriad of possibilities exist for naturally processed(Figure 4A). In fact, the MBP4-Lys, which is known to
epitopes containing the higher affinity sequence(s).result in weak binding to I-Au, is replaced by a Tyr in the
C-terminal sequence, which causes a dramatic affinity
increase. The three pseudo-motif residues apparent in Discussion
the MHC contact residues of 1-7, have been enhanced
in the C-terminal peptide by the substitution of the Tyr, Our principal aim in this study was to provide molecular
insight into the longstanding biochemical questionsas well as the completion of a more canonical length
peptide that has the capacity to fill the entire peptide posed by the weakly binding, immunodominant epitope
of MBP. The short-lived binding of the natural Ac1-11binding groove in a normal register, with all pockets
occupied (Figure 4B) (Fairchild et al., 1993; Fugger et MBP peptide in an unusual register, in a structurally
indiscriminate I-Au groove, leaves approximately one-al., 1996). These features probably combine to render
the C-terminal ten residues superior in binding affinity third of the composite MHC-peptide binding groove un-
occupied. The MBP4-Lys is constrained to occupy anrelative to the 1-7 sequence and therefore displace
Ac1-7 from within the groove (model at the bottom of incompatible, but energetically dominant, p6 pocket by
noncanonical flanking interactions between what wouldFigure 4). In general, class II peptides are 12–15 amino
acids in length, so the higher affinity, longer epitope normally be TCR contact residues and I-Au. These flank-
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ing interactions stabilize the suboptimal register suffi- With the I-Au/MBP1-11 structure, we can now examine
data bearing on molecular mimicry of self-proteinsciently for recognition of MBP1-6 by encephalitogenic
by microbial pathogens, which has been suggested toT cells (Gautam et al., 1994). However, the extremely
be an environmental trigger for the development of auto-short half-life of the complex formed by the binding of
immune diseases (Oldstone, 1987; Wucherpfennig andthe N-terminal epitope of MBP to I-Au results in the
Strominger, 1995). In one study, when the T cell epitopeescape of autoreactive thymocytes from negative selec-
of the MBP Ac1-11 sequence was examined for potentialtion (Liu et al., 1995).
microbial mimics, 832 candidate sequences were identi-This structure further reveals a molecular explanation
fied, of which 61 activated MBP-specific T cells (Groganfor the dramatic affinity increases resulting from exten-
et al., 1999). All of these peptides contained Arg-Pro atsion of the C terminus of the MBP peptide. We find that
P5-P6, and most contained a hydrophobic residue ata high affinity cryptic motif exists in this sequence that
P4. From consideration of both our structure and thesecould bind I-Au in a conventional register with enhanced
sequence identities at key peptide positions, it is clearMHC anchors (Figure 4). The potential of this flanking
that these microbial mimic antigens would assume amotif to mask the presentation of the encephalitogenic
similar noncanonical binding mode as MBP1-11. Hence,MBP1-9 peptide merits consideration as a form of im-
there appears to be a straightforward structural explana-mune subversion, as previously hypothesized by Ser-
tion for the activating potential of such peptides identi-carz and others (Sercarz et al., 1993; Fairchild et al.,
fied in vitro.1996). However, the naturally processed forms of MBP
This structure also provides insight into the strong Vthat might be involved in this register shifting are not
chain bias seen in MBP-specific TCRs (Acha-Orbea etknown and if they exist would presumably be difficult
al., 1988; Urban et al., 1988; Zamvil and Steinman, 1990).to identify due to the induction of negative selection by
It is known from class I and class II TCR/MHC-pep-high affinity, shifted MBP epitopes. Indeed, high affinity,
tide complex structures that the TCR V lies primarilyimmunogenic epitopes of this region of MBP have been
over the peptide N-terminal region, and the V lies overcharacterized, but these epitopes are cryptic and cannot
the C-terminal region (Figure 5) (Garcia et al., 1999;be generated by in vivo MBP processing (Fairchild et
Hennecke and Wiley, 2001; Rudolph and Wilson,al., 1996).
2002). Therefore, the V chain bias is likely explainedThe broader implications of this structure are that
by the majority of the MBP peptide epitope residingpeptides binding in noncanonical and/or frame-shifted
within the C-terminal region of the I-Au groove, under-registers, which has been previously suggested as a
neath the presumed TCR V footprint. The availablepossibility (Sercarz et al., 1993; Fairchild et al., 1996;
crystal structure coordinates for two TCR V8.2 chainsLee et al., 1998; McFarland et al., 1999), can, in fact,
in complex with a class I MHC (2C TCR/H-2Kb-dEV8)occur. It would appear that I-A MHC, which are fre-
and class II MHC (D10 TCR/I-Ak-CA) (Garcia et al., 1996,quently the restricting elements associated with autoim-
1998; Reinherz et al., 1999) allow us to speculate onmunity, would be particularly prone to peptide frame-
TCR(V8.2)/I-Au-Ac1-11 interactions. The two com-shifting due to their relatively promiscuous grooves that
plexes span the range of orientation angles seen in TCR-
lead to extensive crossreactivity with peptides (Fremont
MHC complexes, from the more diagonal seen in 2C/Kb
et al., 1998; Scott et al., 1998). Register-shifting adds
to the less diagonal seen in D10/I-Ak. A constraint in this
an additional dimension to the concept of T cell cross- analysis is that the V8 chain bias is antigen specific,
reactivity, in that TCRs are clearly capable of recognizing so that there is almost certainly direct contact between
noncanonical and shifted registers that would not be the TCR CDR1 and/or CDR2 and the MBP peptide.
predicted using conventional TCR epitope alignments In the D10/I-Ak complex, there is no CDR1 or CDR2
(McFarland et al., 1999; Garcia et al., 2001). The implica- contact with peptide, indicating that this orientation is
tions for autoimmunity are that many noncanonical and/ unlikely for MBP-specific TCRs (Reinherz et al., 1999).
or frame-shifted peptide registers are energetically unfa- Rather, in the 2C/H-2Kb complex, CDR1 and CDR2
vorable due to burial of N- or C-terminal charges in are oriented more over the C-terminal region of the
the groove and incompatible pockets. As such, these groove, in close proximity to the peptide (Garcia et al.,
registers make transient complexes that may, like MBP, 1998). The region of the peptide that CDR1 and CDR2
be poor inducers of negative selection of autoreactive will likely overlay in the complex, by extension from
T cells. the four known TCR-pMHC complexes (Rudolph and
Wilson, 2002), is centered at the P6-Pro in the I-Au/
T Cell Epitope MBP1-11 complex. Together, this cluster of amino acids
The vast majority of T cells directed against the Ac1-11 presents a nonpolar patch to a TCR. One possible sce-
epitope are sensitive to substitution of MBP residues nario for recognition of I-Au/MBP1-11 is that the TCR
MBP3-Gln, MBP5-Arg, and MBP6-Pro (Anderton et al., orientation is rotated so that the conserved V8 Tyr50
could form a contact with this nonpolar patch. Further1998; Wraith et al., 1989). From our structure, it is clear
structural studies will be required to gain further insightthat these are the three most solvent exposed residues
into the molecular details of TCR recognition (Thatte etand would, therefore, be the preferred TCR contacts. In
al., 1999) of this unusual peptide-MHC complex.some T cell clones, such as 1934.4, there is some flexibil-
ity in the allowed substitutions at MBP3, but a strict
Experimental Proceduresrequirement for the MBP6-Pro is maintained (Anderton
et al., 1998). For the more crossreactive 172.10 T cells, Protein Expression and Purification
multiple substitutions are allowed at MBP6 with less The coding sequences for the extracellular domains of I-Au  and
 chains were amplified by PCR and subcloned into the pRMHa3tolerance for MBP3 alterations (Anderton et al., 1998).
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expression vector for expression in Drosophila melanogaster (Scott molecules were eluted with 50 mM diethylamine in 0.15 M NaCl
containing 0.4% n-octylglucoside (pH 11.5). A 1/25 volume of 2.0et al., 1996). The MBP1-11 sequence, with an additional N-terminal
Gly residue to mimic the acetylation, was linked to the  chain N M Tris (pH 6.8) was added to the eluate to reduce the pH to 8.0.
The eluate was concentrated by centrifugation in Centriprep 30terminus through an eight residue GlySer linker. The C termini of
each chain were cloned in frame with a Rhinovirus-C protease site concentrators at 2000 rpm (Amicon, Beverly, MA).
that was linked to acidic or basic leucine zippers, followed by hexa-
histidine tags. Methodology for expression of class II MHC from I-Au Peptide Binding Assays
Drosophila melanogaster is as previously described (Scott et al., Quantitative peptide-I-Au binding assays were based on the inhibi-
1996). The zippered MHC was cleaved with Rhino-C protease and tion of binding of radiolabeled ROIV peptide (sequence YAHAAHAA
digested with carboxypeptidase-A (1:100) prior to purification by HAAHAAHAA, IC50 of ROIV was 20 nM [Sette et al., 1990]). Assays
mono-Q and superdex-200 gel filtration FPLC (Pharmacia, NJ). As were performed by coincubating purified I-Au molecules (5 to 500
a final step, the proteins were concentrated by centricon (Millipore) nM) for 48 hr with various concentrations (120 M to 120 nM) of
to 15mg/ml in HBS, sterile-filtered, and stored at 4C. unlabeled peptide inhibitors and 1–10 nM 125I-radiolabeled ROIV.
Expression and functional characterization of an I-Au/MBP1-11 The reaction was done at pH 7.0 in PBS containing 0.7% digitonin.
complex from baculovirus, using a honey bee mellitin secretion For all assays, ROIV peptide was radiolabeled using the chlora-
signal, has been previously described (Radu et al., 1998). mine-T method (Sidney et al., 1998) and purified by size exclusion
gel filtration HPLC (TosoHaas 16215, Montgomeryville, PA).
T Cell Activation Assays In preliminary experiments, I-Au preparations were titered in the
172.10 hybridoma cells (Urban et al., 1988; a generous gift of Dr. presence of a fixed amount of radiolabeled ROIV to determine the
Joan Goverman) were used in these assays. Hybridomas (5  104 concentration of I-Au molecules necessary to bind 10%–20% of
cells/well) were incubated with plate-bound I-Au/MBP1-11 com- the total radioactivity. In competitive assays, the concentration of
plexes as described (Radu et al., 1998). Cells were stimulated for peptide yielding 50% inhibition of the binding or the radiolabeled
24 hr and IL-2 levels in culture supernatants quantitated by IL-2 peptide was calculated. Under the conditions utilized, where [la-
ELISA. beled peptide]  [MHC] and IC50 
 [MHC], the measured IC50
values are reasonable approximations of true KD values. Peptides
were tested in two to four completely independent experiments.Crystallization, Data Collection, and Processing
The crystals of Drosophila-expressed I-Au were grown from 20%
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